Olaf Hardt R&D Reagents Miltenyi Biotec GmbH Biography Publications Institution JoVE Articles Olaf Hardt has not added a biography. If you are Olaf Hardt and would like to personalize this page please email our Author Liaison for assistance. Publications The Sialyl-glycolipid Stage-specific Embryonic Antigen 4 Marks a Subpopulation of Chemotherapy-resistant Breast Cancer Cells with Mesenchymal Features Breast Cancer Research : BCR. 2015 | Pubmed ID: 26607327 Transcriptional Pathways in CPGI2-Induced Adipocyte Progenitor Activation for Browning Frontiers in Endocrinology. 2015 | Pubmed ID: 26347713 Comparison Between Cold Plasma, Electrochemotherapy and Combined Therapy in a Melanoma Mouse Model Experimental Dermatology. Sep, 2013 | Pubmed ID: 23947672 Highly Sensitive Profiling of CD44+/CD24- Breast Cancer Stem Cells by Combining Global MRNA Amplification and Next Generation Sequencing: Evidence for a Hyperactive PI3K Pathway Cancer Letters. Dec, 2012 | Pubmed ID: 22771536 NeuroD1は、嗅覚神経発生におけるターミナル神経分化を誘導する Proceedings of the National Academy of Sciences of the United States of America. Jan, 2010 | Pubmed ID: 20080708 遺伝子発現解析は、地域固有のGABA作動性ニューロンの相違点を定義します。 Molecular and Cellular Neurosciences. Nov, 2008 | Pubmed ID: 18725299 Characterization of Peptides Released from Mitochondria: Evidence for Constant Proteolysis and Peptide Efflux The Journal of Biological Chemistry. Jan, 2005 | Pubmed ID: 15556950 ヒト腫瘍異種移植片からマウス細胞の枯渇は大幅に標的細胞の下流分析を向上させます David J. Agorku1, Stefan Tomiuk1, Kerstin Klingner2, Stefan Wild1, Silvia Rüberg1, Lisa Zatrieb1, Andreas Bosio1, Julia Schueler2, Olaf Hardt1 1R&D Reagents, Miltenyi Biotec GmbH, 2In vivo Tumorbiology, Oncotest GmbH JoVE 54259 Medicine
ヒト腫瘍異種移植片からマウス細胞の枯渇は大幅に標的細胞の下流分析を向上させます David J. Agorku1, Stefan Tomiuk1, Kerstin Klingner2, Stefan Wild1, Silvia Rüberg1, Lisa Zatrieb1, Andreas Bosio1, Julia Schueler2, Olaf Hardt1 1R&D Reagents, Miltenyi Biotec GmbH, 2In vivo Tumorbiology, Oncotest GmbH JoVE 54259 Medicine